Garlic (Allium sativum L. fam. Alliaceae) is one of the best-researched, best-selling herbal remedies and is also commonly used as a food and a spice. Garlic constituents include enzymes (for example, alliinase) and sulfur-containing compounds, including alliin, and compounds produced enzymatically from alliin (for example, allicin). Traditionally, it has been employed to treat infections, wounds, diarrhea, rheumatism, heart disease, diabetes, and many other disorders. Experimentally, it has been shown to exert antilipidemic, antihypertensive, antineoplastic, antibacterial, immunostimulant and hypoglycemic actions. Clinically, garlic has been evaluated for a number of conditions, including hypertension, hypercholesterolemia, intermittent claudication, diabetes, rheumatoid arthritis, common cold, as an insect repellent, and for the prevention of arteriosclerosis and cancer. Systematic reviews are available for the possible antilipidemic, antihypertensive, antithrombotic and chemopreventive effects. However, the clinical evidence is far from compelling. Garlic appears to be generally safe although allergic reactions may occur.
RivlinRS. (2001) Historical perspective on the use of garlic. Journal of Nutrition, 131, 9515–9545.
2.
BanerjeeSK, MaulikSK. (2002) Effect of garlic on cardiovascular disorder: a review. Journal of Nutrition, 136, 1–14.
3.
RahmanK, LoweGM. (2006) Garlic and cardiovascular disease: a critical review. Journal of Nutrition, 136, 736S–740S.
4.
AmagaseH, PeteschBL, MatsuuraH, KasugaS, ItakuraY. (2001) Intake of garlic and its bioactive components. Journal of Nutrition, 131, 9555–9625.
5.
NaginiS. (2008) Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise?Anticancer Agents in Medicinal Chemistry, 8, 313–321.
6.
SekiT, HosonoT, Hosono-FukaoT, InadaK, TanakaR, OgiharaJ, ArigaT. (2008) Anticancer effects of diallyl trisulfide derived from garlic. Asia Pacific Journal of Clinical Nutrition, 17, 249–252.
7.
MünchbergU, AnwarA, MecklenburgS, JacobC. (2007) Polysulfides as biologically active ingredients of garlic. Organic & Biomolecular Chemistry, 5, 1505–1518.
8.
BlockE. (1985) The chemistry of garlic and onions. Scientific American, 252, 114–119.
9.
LawsonLD, WangZJ. (2005) Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: use in measuring allicin bioavailability. Journal of Agriculture and Food Chemistry, 53, 1974–1983.
10.
KochHP, HahnG, LawsonL, ReuterHD, SiegersCP. (1996) Garlic. The science and the therapeutic applications of Allium sativum L. and related species. 2nd Ed, Williams and Wilkins.
11.
JandkleJ, SpitellerG. (1987) Unusual conjugates in biological profiles originating from consumption of onions and garlic. Journal of Chromatography, 421, 1–8.
12.
MennellaJA, BeauchampGK. (1991) Maternal diet alters the sensory qualities of human milk and the nursling's behaviour. Pediatrics, 88, 737–744.
13.
BanerjeaSK, MukherjeePK, MauliKSK. (2003) Garlic as an antioxidant: the good, the bad and the ugly. Phytotherapy Research, 17, 97–106.
14.
RahmanK. (2007) Effects of garlic on platelet biochemistry and physiology. Molecular Nutrition & Food Research, 51, 1335–1344.
15.
DevrimE, DurakI. (2007) Is garlic a promising food for benign prostatic hyperplasia and prostate cancer?Molecular Nutrition & Food Research, 51, 1319–1323.
16.
MilnerJA. (1996) Garlic: its anticarcinogenic and antitumorigenic properties. Nutrition Reviews, 54, 582–586.
17.
AdetumbiM, LauBHS. (1983) Allium sativum (garlic) a natural antibiotic. Medical Hypotheses, 12, 227–237.
18.
FulderS. (1989) Garlic and the prevention of cardiovascular disease. Cardiology Practice, 7, 30–35.
19.
BorekC. (2001) Antioxidant health effects of aged garlic extract. Journal of Nutrition, 131, 51010–51015.
20.
YheY-Y, LiuL. (2001) Cholesterol-lowering effect of garlic extract and organosulfur compounds: human and animal studies. Journal of Nutrition, 131, 5989–5993.
21.
Le BonA-M, SinessM-H. (2001) Organosulfur compounds from Allium and the chemoprevention of cancer. Drug Metabolism and Drug Interaction, 17, 51–79.
22.
QureshiAA, AbiurmeilehN, DinZZ, ElsonCE, BurgerWC. (1983) Inhibition of cholesterol and fatty acid biosynthesis in liver enzymes and chicken hepatocytes by polar fractions of garlic. Lipids, 18, 343–348.
23.
GebhardtR. (1993) Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids, 28, 613–619.
24.
GebhardtR. (1995) Amplification of palmitate-induced inhibition of cholesterol biosynthesis in cultured rat hepatocytes by garlic-derived organosulfur compounds. Phytomedicine, 2, 29–34.
25.
GuptaN, PorterTD. (2001) Garlic and garlic-derived compounds inhibit human squalene monooxygenase. Journal of Nutrition, 131, 1662–1667.
26.
SinghDK, PorterTD. (2006) Inhibition of sterol 4α-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. Journal of Nutrition, 136, 759S–764S.
27.
SheelaCG, AugustiKT. (1995) Effects of S-allyl cysteine sulfoxide isolated from Allium sativum Linn and gugulipid on some enzymes and faecal excretions of bile acids and sterols in cholesterol fed rats. Indian Journal of Experimental Biology, 33, 749–751.
28.
LiuL, YheY-Y. (2001) Water-soluble organosulfur compounds of garlic inhibit fatty acid and triglyceride synthesis in cultured rat hepatocytes. Lipids, 36, 395–400.
29.
CampbellJH, EfendyJL, SmithNJ, CampbellGR. (2001) Molecular basis by which garlic suppresses atherosclerosis. Journal of Nutrition, 131, 1006–1009.
30.
AbramowitzD. (1999) Allicin-induced decrease in formation of fatty steaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coronary Artery Disease, 10, 515–519.
31.
GorinsteinS, JastrzebskiZ, NamiesnikJ, LeontowiczH, LeontowiczM, TrakhtenbergS. (2007) The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Molecular Nutrition & Food Research, 51, 1365–1381.
32.
ChandorkarAG, JainPK. (1973) Analysis of hypertensive action of Allium sativum (garlic). Indian Journal of Physiology and Pharmacology, 17, 132–133.
33.
MalikZA, SiddiquiS. (1981) Hypotensive effect of freeze-dried garlic (Allium sativum) SAP in dog. Journal of the Pakistan Medical Association, 31, 12–13.
34.
Al-QattanKK, AlnaqeebMA, AliM. (1999) The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney-one-clip Goldblatt model. Journal of Ethnopharmacology, 66, 217–222.
35.
AliM, Al-QattanKK, Al-EneziF, KhanaferRM, MustafaT. (2000) Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins, Leukotrienes & Essential Fatty Acids, 62, 253–259.
36.
JacobR, RhrsamM, OhkuboT, RuppH. (1991) Antihypertensive and kardioprotektive effekt von knoblauchpulver (Allium sativum). Medizinische Welt, 7, 39–41.
37.
SiegelG, EmdenJ, WenzelK, MironneauJ, StockG. (1992) Potassium channel activation in vascular smooth muscle. In: FrankGB. (Ed.). Excitation-contracting coupling in skeletal, cardiac and smooth muscle. Plenum Press, New York.
38.
DasI, KhanNS, SoorannaSR. (1995) Potent activation of nitric oxide synthase by garlic: a base for its therapeutic applications. Current Medical Research and Opinion, 13, 257–263.
39.
Kim-ParkS, KuDD. (2000) Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clinical and Experimental Pharmacology and Physiology, 27, 780–786.
40.
BoullinDJ. (1981) Garlic as a platelet inhibitor. Lancet, 1, 776–777.
41.
GaffenJD, TavaresIA, BennettA. (1984) The effect of garlic extracts on contractions of rat gastric fundus and human platelet aggregation. Journal of Pharmacy and Pharmacology, 36, 272–274.
42.
SrivastavaKC. (1986) Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostaglandins, Leukotrienes and Medicine, 22, 313–321.
43.
Apitz-CastroR, CabreraS, CruzMR, LedezmaE, JainMK. (1983) Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thrombosis Research, 32, 155–169.
44.
WagnerH, WiererM, FesslerB. (1987) Effects of garlic constituents on arachidonate metabolism. Planta Medica, 53, 305–306.
45.
SharmaCP, NirmalaNV. (1985) Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure–comments. Thrombosis Research, 37, 489–490.
46.
CipleaAG, RichterKD. (1988) The protective effect of Allium sativum and Crataegus on isoprenaline-induced tissue necrosis in rats. Arzneimittel-Forschung, 38, 1583–1592.
SiegersCP, RöbkeA, PentzR. (1999) Effects of garlic preparations on superoxide production by phorbol ester activated granulocytes. Phytomedicine, 6, 13–16.
49.
KourounakisPN, RekkaEA. (1991) Effect of active oxygen species of alliin and Allium sativum (garlic) powder. Research Communications in Chemical Pathology & Pharmacology, 74, 249–252.
50.
IdeN, LauBH. (1997) Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. Journal of Pharmacy and Pharmacology, 49, 908–911.
51.
LewinG, PopovI. (1994) Antioxidant effects of aqueous garlic extract. 2nd communication: Inhibition of the Cu(2+)-initiated oxidation of low density lipoproteins. Arzneimittel-Forschung, 44, 604–607.
52.
PopovI, BlumsteinA, LewinG. (1994) Antioxidant effects of aqueous garlic extract. 1st communication: Direct detection using the photochemiluminescence. Arzneimittel-Forschung, 44, 602–604.
53.
TörökB, BelágyiJ, RietzB, JacobR. (1994) Effectiveness of garlic on the radical activity in radical generating systems. Arzneimittel-Forschung, 44, 608–611.
54.
Herman-AntosiewiczA, PowolnyAA, SinghSV. (2007) Molecular targets of cancer chemoprevention by garlic-derived organosulfides. Acta Pharmacologica Sinica, 28, 1355–1364.
55.
El-BayoumyK, SinhaR, PintoJT, RivlinRS. (2006) Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. Journal of Nutrition, 136, 864S–869S.
56.
MilnerJA. (2006) Preclinical perspectives on garlic and cancer. Journal of Nutrition, 136, 827S–831S.
57.
KhanumF, AnilakumarKR, ViswanathanKR. (2004) Anticarcinogenic properties of garlic: a review. Critical Reviews in Food Science and Nutrition, 44, 479–488.
58.
PintoJT, LapsiaS, ShahA, SantiagoH, KimG. (2001) Antiproliferative effects of garlic-derived and other Allium related compounds. Advances in Experimental Medicine and Biology, 492, 83–106.
59.
BianchiniF, VainioH. (2001) Allium vegetables and organosulfur compounds: do they help prevent cancer?Environmental Health Perspectives, 109, 893–902.
60.
SharmaVD, SethiMS, KumarA, RarotraJR. (1977) Antibacterial property of Allium sativum Linn.: in vivo & in vitro studies. Indian Journal of Experimental Biology, 15, 466–468.
61.
KumarM, BerwalJS. (1998) Sensitivity of food pathogens to garlic (Allium sativum). Journal of Applied Microbiology, 84, 213–215.
62.
DavisLE, ShenJ, RoyerRE. (1994) In vitro synergism of concentrated Allium sativum extract and amphotericin B against Cryptococcus neoformans. Planta Medica, 60, 546–549.
63.
RossZM, O'GaraEA, HillDJ, SleightholmeHV, MaslinDJ. (2001) Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder. Applied and Environmental Microbiology, 67, 475–480.
64.
ShashikanthKN, BasappaSC, SreenivasaMurthy V. (1984) A comparative study of raw garlic extract and tetracycline on caecal microflora and serum proteins of albino rats. Folia Microbiologica, 29, 348–352.
65.
LammDL, RiggsDR. (2000) The potential application of Allium sativum (garlic) for the treatment of bladder cancer. Urologic Clinics of North America, 27, 157–162.
ReuterHD, SendlA. (1994) Alium sativum and Allium ursinum: Chemistry, Pharmacology and Medicinal Applications. In WagnerH. (Ed.), Economic and medicinal plant research, 6. Academic Press, London, 55–113.
68.
LiuC-T, SheenL-Y, LiiC-K. (2007) Does garlic have a role as an antidiabetic agent?Molecular Nutrition & Food Research, 51, 1353–1364.
69.
StevinsonC, PittlerMH, ErnstE. (2000) Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Annals of Internal Medicine, 133, 420–429.
70.
ErnstE, PittlerMH, WiderB, BoddyK. (2008) The Oxford Handbook of Complementary Medicine, Oxford University Press, Oxford.
71.
KhooYSK, AzizZ. (2009) Garlic supplementation and serum cholesterol: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 34, 133–145.
72.
ReinhartKM, ColemanCI, TeevanC, VachhaniP, WhiteCM. (2008) Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Annals of Pharmacotherapy, 42, 1766–1771.
73.
RiedK, FrankOR, StocksNP, FaklerP, SullivanT. (2008) Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovascular Disorders, 8, 13–24.
74.
MeherS, DuleyL. (2006) Garlic for preventing pre-eclampsia and its complications. Cochrane Database Systematic Reviews, 3, CD006065.
75.
KoscielnyJ, KlussendorfD, LatzaR, SchmittR, RadtkeH, SiegelG, KiesewetterH. (1999) The antiatherosclerotic effect of Allium sativum. Atherosclerosis144, 237–249.
76.
Breithaupt-GroglerK, LingM, BoudoulasH, BelzGG. (1997) Protective effect of chronic garlic intake on elastic properties of aorta in the elderly. Circulation, 96, 2649–2655.
77.
BudoffM. (2006) Aged garlic extract retards progression of coronary artery calcification. Journal of Nutrition, 136, 741S–744S.
78.
Herman-AntosiewiczA, SinghSV. (2004) Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutation Research, 555, 121–131.
79.
MilnerJA. (2001) Mechanisms by which garlic and allyl sulphur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Advances in Experimental Medicine and Biology, 492, 69–81.
80.
SheenLY, ChenHW, KungYL, LiuCT and LiiCK. (1999) Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed high- and low-fat diets. Nutrition and Cancer, 35, 160–166.
81.
GermainE, ChevalierJ, SiessMH, TeyssierC. (2003) Hepatic metabolism of diallyl disulphide in rat and man. Xenobiotica33, 1185–1199.
82.
ChenC, PungD, LeongV, HebbarV, ShenG, NairS, LiW and KongAN. (2004) Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radical Biology and Medicine, 37, 1578–1590.
83.
GongP, HuB, CederbaumAI. (2004) Diallyl sulphide induces heme oxygenase-1 through MAPK pathway. Archives of Biochemistry and Biophysics, 432, 252–260.
84.
KimJY, KwonO. (2009) Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. American Journal of Clinical Nutrition, 89, 257–264.
85.
NgoSNI, WilliamsDB, CobiacL, HeadRJ. (2007) Does garlic reduced risk of colorectal cancer? A systematic review. Journal of Nutrition, 137, 2264–2269.
86.
AckermannRT, MulrowCD, RamirezG, GardnerCD, MorbidoniL, LawrenceVA. (2001) Garlic shows promise for improving some cardiovascular risk factors. Archives of Internal Medicine, 161, 813–824.
IzzoAA. (2007) Efficacy and safety of Allium sativum (garlic). Focus on Alternative and Complementary Therapies, 12, 162–166.
89.
AlvarezMS, JacobsS, JiangSB, BrancaccioRR, SoterNA, CohenDE. (2003) Photocontact allergy to diallyl disulfide. American Journal of Contact Dermatitis, 14, 161–165.
90.
BorrelliF, CapassoR, IzzoAA. (2007) Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Molecular Nutrition & Food Research, 51, 1386–1397.
91.
BlumenthalM, BusseWR, GoldbergA, GruenwaldJ, HallT, RigginsCW, RisterRS., (Eds). (1998) The complete German Commission E monographs: therapeutic guide to herbal medicines.American Botanical Council, Austin, TX.
92.
HoshinoT, KashimotoN, KasugaS. (2001) Effects of garlic preparations on the gastrointestinal mucosa. Journal of Nutrition, 131, 1109S–1113S.
93.
BeckE, GrunwaldJ. (1993) Allium sativum in der Stufentherapie der Hyperlipidaemie. Medizinische Welt, 44, 516–520.
94.
PapageorgiouC, CorbetJP, Menezes-BrandaoF, PecegueiroM, BenezraC. (1983) Allergic contact dermatitis to garlic (Allium sativum L.). Identification of the allergens: the role of mono-, di-, and trisulfides present in garlic. A comparative study in man and animal (guinea-pig). Archives of Dermatology Research, 275, 229–234.
95.
KaoSH, HsuCH, SuSN, HorWT, ChangT WH, ChowLP. (2004) Identification and immunologic characterization of an allergen, alliin lyase, from garlic (Allium sativum). Journal of Allergy Clinical Immunology, 113, 161–188.
96.
BaggeS, ThomasBS, BhatM. (2008) Garlic burn as self-inflicted mucosal injury- a case report and review of the literature. Quintessence International, 39, 491–494.
97.
BojsG, SvenssonA. (1988) Contact allergy to garlic used for wound healing. Contact Dermatitis, 18, 179–181.
MacanH, UykimpangR, AlconcelM, TakasuJ, RazonR, AmagaseH, NiiharaY. (2006) Aged garlic extract may be safe for patients on warfarin therapy. Journal of Nutrition, 136, 793S–795S.
107.
MohammedAbdul MI, JiangX, WilliamsKM, DayRO, RoufogalisBD, LiauwWS, XuH, McLachlanAJ. (2008) Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. British Journal of Pharmacology, 154, 1691–1700.
108.
PiscitelliSC, BursteinAH, WeldenN, GallicanoKD, FalloonJ. (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clinical Infectious Diseases, 34, 234–238.
109.
GallicanoK, FosterB, ChoudhriS. (2003) Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. British Journal of Clinical Pharmacology, 55, 199–202.
110.
LarocheM, ChoudhuriS, GallicanoK, FosterB. (1998) Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. The Canadian Journal of Infectious Diseases, 9, 471.
